O. Pierre-Louis

A Cross‐Talk Between Stromal Cell‐Derived Factor‐1 and Transforming Growth Factor‐β Controls the Quiescence/Cycling Switch of CD34+ Progenitors Through FoxO3 and Mammalian Target of Rapamycin

M. Le Bousse-Kerdilès, A. Bennaceur-Griscelli, L. Abécassis, 2008, Stem cells.

FLT3-mediated p38-MAPK activation participates in the control of megakaryopoiesis in primary myelofibrosis.

W. Vainchenker, V. Lazar, P. Guglielmelli, 2007, Cancer research.

Does primary myelofibrosis involve a defective stem cell niche? From concept to evidence.

M. Le Bousse-Kerdilès, H. Hasselbalch, C. Jasmin, 2008, Blood.

Dual SP/ALDH Functionalities Refine the Human Hematopoietic Lin−CD34+CD38− Stem/Progenitor Cell Compartment

M. Le Bousse-Kerdilès, A. Bennaceur-Griscelli, C. Desterke, 2009, Stem cells.

Osteogenic Potential of Mesenchymal Stromal Cells Contributes to Primary Myelofibrosis.

M. Le Bousse-Kerdilès, A. Vannucchi, M. Bourgeade, 2015, Cancer research.

Expression of HMGA2 in PB leukocytes and purifiedCD34+ cells from controls and patients with Myelofibrosis andmyeloid metaplasia

M. Le Bousse-Kerdilès, E. Lippert, V. Praloran, 2006, Leukemia & lymphoma.